<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(1)</volume><submitter>Vieira Neto E</submitter><funding>UPMC Children's Hospital of Pittsburgh Foundation</funding><funding>Children's Neuroscience Institute Interdisciplinary Neuroscience Award</funding><pubmed_abstract>Mitochondrial trifunctional protein (TFP) deficiency is an inherited disorder of long-chain fatty acid β-oxidation (FAO). TFP is a heteromeric enzyme composed of two α and two β-subunits. Despite early detection and dietary treatment, TFP deficiency patients often develop hypoglycemia, rhabdomyolysis, cardiomyopathy, and peripheral neuropathy. Degenerative retinopathy and milder peripheral neuropathy occur in patients with an isolated deficiency of the αTFP subunit of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) activity. Triheptanoin treatment improves most complications, but not peripheral neuropathy and retinopathy. Notably, TFP also carries a fourth enzymatic function involved in cardiolipin remodeling, which we previously found to be impaired in TFP/LCHAD deficiency. We therefor</pubmed_abstract><journal>Journal of inherited metabolic disease</journal><pagination>e70132</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12779498</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts.</pubmed_title><pmcid>PMC12779498</pmcid><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Ferraro L</pubmed_authors><pubmed_authors>Szuminsky AJ</pubmed_authors><pubmed_authors>Basu S</pubmed_authors><pubmed_authors>Vockley J</pubmed_authors><pubmed_authors>Vieira Neto E</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors><pubmed_authors>Karunanidhi A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts.</name><description>Mitochondrial trifunctional protein (TFP) deficiency is an inherited disorder of long-chain fatty acid β-oxidation (FAO). TFP is a heteromeric enzyme composed of two α and two β-subunits. Despite early detection and dietary treatment, TFP deficiency patients often develop hypoglycemia, rhabdomyolysis, cardiomyopathy, and peripheral neuropathy. Degenerative retinopathy and milder peripheral neuropathy occur in patients with an isolated deficiency of the αTFP subunit of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) activity. Triheptanoin treatment improves most complications, but not peripheral neuropathy and retinopathy. Notably, TFP also carries a fourth enzymatic function involved in cardiolipin remodeling, which we previously found to be impaired in TFP/LCHAD deficiency. We therefor</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-06T11:31:00.649Z</modification><creation>2026-05-29T03:12:55.475Z</creation></dates><accession>S-EPMC12779498</accession><cross_references><pubmed>41500837</pubmed><doi>10.1002/jimd.70132</doi></cross_references></HashMap>